Argentina · Delayed Price · Currency is ARS CTI BioPharma Statistics
Total Valuation
BCBA:BMY has a market cap or net worth of ARS 121.00 trillion. The enterprise value is 171.69 trillion.
| Market Cap | 121.00T |
| Enterprise Value | 171.69T |
Important Dates
The last earnings date was Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.03B |
Valuation Ratios
The trailing PE ratio is 20.11 and the forward PE ratio is 7.17.
| PE Ratio | 20.11 |
| Forward PE | 7.17 |
| PS Ratio | 2.13 |
| PB Ratio | 5.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 28.54 |
| EV / Sales | 2.78 |
| EV / EBITDA | 6.45 |
| EV / EBIT | 9.52 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 2.94 |
| Debt / EBITDA | 2.50 |
| Debt / FCF | n/a |
| Interest Coverage | 7.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 12.43% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.67B |
| Profits Per Employee | 176.45M |
| Employee Count | 34,100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCBA:BMY has paid 1.82 trillion in taxes.
| Income Tax | 1.82T |
| Effective Tax Rate | 23.18% |
Stock Price Statistics
The stock price has decreased by -4.71% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -4.71% |
| 50-Day Moving Average | 19,418.00 |
| 200-Day Moving Average | 21,424.25 |
| Relative Strength Index (RSI) | 53.11 |
| Average Volume (20 Days) | 1,565 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BCBA:BMY had revenue of ARS 56.85 trillion and earned 6.02 trillion in profits. Earnings per share was 2,962.53.
| Revenue | 56.85T |
| Gross Profit | 42.36T |
| Operating Income | 16.56T |
| Pretax Income | 7.86T |
| Net Income | 6.02T |
| EBITDA | 24.28T |
| EBIT | 16.56T |
| Earnings Per Share (EPS) | 2,962.53 |
Balance Sheet
The company has 14.04 trillion in cash and 61.10 trillion in debt, giving a net cash position of -46,649.10 billion.
| Cash & Cash Equivalents | 14.04T |
| Total Debt | 61.10T |
| Net Cash | -46,649.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.79T |
| Book Value Per Share | 10,183.03 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 74.52%, with operating and profit margins of 29.14% and 10.58%.
| Gross Margin | 74.52% |
| Operating Margin | 29.14% |
| Pretax Margin | 13.82% |
| Profit Margin | 10.58% |
| EBITDA Margin | 42.72% |
| EBIT Margin | 29.14% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 652.40, which amounts to a dividend yield of 3.22%.
| Dividend Per Share | 652.40 |
| Dividend Yield | 3.22% |
| Dividend Growth (YoY) | 77.00% |
| Years of Dividend Growth | 8 |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 3.20% |
| Earnings Yield | 4.97% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 22, 2020. It was a forward split with a ratio of 3.0000300003.
| Last Split Date | Oct 22, 2020 |
| Split Type | Forward |
| Split Ratio | 3.0000300003 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |